TRIPTYCH THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 11 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99077321
- Mark type
- Stylized text
- Filed
- 11 Mar 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Kristin H. Altoff
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of autoimmune, inflammatory, and allergic diseases; therapeutic pharmaceuticals and biological preparations for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases; biologics preparations, namely, antibodies and antibody-containing polypeptide complexes for medical or clinical use for the treatment of autoimmune, inflammatory, and allergic diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development services for the treatment of autoimmune, inflammatory, and allergic diseases
Owner
- Triptych Therapeutics Management, Inc., Boston, MA, US
- Triptych Therapeutics Management, Inc., Boston, MA, US
Prosecution history
- 11 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 1 GRANTED
- 11 Mar 2026 — SOU EXTENSION 1 FILED
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 19 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 19 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Aug 2025 — NON-FINAL ACTION E-MAILED